首页> 外文期刊>JAMA: the Journal of the American Medical Association >Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group.
【24h】

Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group.

机译:帕金森病白天过度嗜睡和突然发作的睡眠:加拿大运动障碍小组的一项调查。

获取原文
获取原文并翻译 | 示例
           

摘要

CONTEXT: Somnolence is a recognized adverse effect of dopamine agonists. Two new dopamine agonists, pramipexole and ropinirole, have been reported to cause sudden-onset sleep spells in patients with Parkinson disease (PD) while they were driving. The frequency of these spells and whether driving should be restricted has yet to be established. OBJECTIVE: To determine the frequency of and predictors for sudden-onset sleep and, particularly, episodes of falling asleep while driving among patients with PD. DESIGN, SETTING, AND PARTICIPANTS: Prospective survey conducted between January and April 2000 in 18 clinics directed by members of the Canadian Movement Disorders Group; 638 consecutive highly functional PD patients without dementia were enrolled, of whom 420 were currently drivers. MAIN OUTCOME MEASURES: Excessive daytime sleepiness and sudden-onset sleep as assessed by the Epworth Sleepiness Scale and the Inappropriate Sleep Composite Score. The latter score, designed for this study, addressed falling asleep in unusual circumstances. The 2 scales were combined in 3 separate formats: dozing off, sudden unexpected sleep, and sudden blank spells. RESULTS: Excessive daytime sleepiness was present overall in 327 (51%) of the 638 patients and in 213 (51%) of the 420 drivers. Patients taking a variety of different dopamine agonists had no differences in Epworth sleepiness scores, in the composite score, or in the risk of falling asleep while driving. Sixteen patients (3.8%) had experienced at least 1 episode of sudden onset of sleep while driving (after the diagnosis of PD); in 3 (0.7%), it occurred without warning. The 2 risk factors associated with falling asleep at the wheel were the Epworth Sleepiness Scale score (odds ratio [OR], 1.14; 95% confidence interval [CI], 1.06-1.24) and the Inappropriate Sleep Composite Score (OR, 2.54; 95% CI, 1.76-3.66). A standard Epworth Sleepiness Scale score of 7 or higher predicted 75% of episodes of sleep behind the wheel at a specificity of 50% (exclusion of the question related to driving provided 70% sensitivity and 52% specificity), whereas a score of 1 on the Inappropriate Sleep Composite Score generated a sensitivity of 52% and specificity of 82%. CONCLUSIONS: Excessive daytime sleepiness is common even in patients with PD who are independent and do not have dementia. Sudden-onset sleep without warning is infrequent. The Epworth score has adequate sensitivity for predicting prior episodes of falling asleep while driving and its specificity can be increased by use of the Inappropriate Sleep Composite Score. It is unknown if routinely performing these assessments could be more effective in predicting future risk for these rare sleep attacks. Patients should be warned not to drive if they doze in unusual circumstances.
机译:背景:嗜睡是多巴胺激动剂的公认不良反应。据报道,两种新的多巴胺激动剂普拉克索和罗匹尼罗在驾驶时会导致帕金森病(PD)患者突然发作睡眠。这些咒语的频率以及是否应该限制驾驶尚待确定。目的:确定PD患者中突然发作的睡眠的频率和预测因素,尤其是开车时入睡的次数。设计,地点和参加者:2000年1月至2000年4月在由加拿大运动障碍小组成员指导的18家诊所进行了前瞻性调查;连续招募了638例无痴呆的高功能PD患者,其中目前有420位驾驶员。主要观察指标:通过爱泼华嗜睡量表和不适当的睡眠综合评分来评估白天过度嗜睡和突然发作的睡眠。为这项研究而设计的后者得分是针对在异常情况下入睡的。这2个音阶以3种不同的格式组合:打off睡,突然的意想不到的睡眠和突然的空白咒语。结果:638名患者中的327名(51%)和420名驾驶员中的213名(51%)总体上存在白天过度嗜睡。服用各种不同的多巴胺激动剂的患者在Epworth嗜睡性评分,综合评分或驾驶时入睡的风险均无差异。 16名患者(3.8%)在驾车时(诊断为PD后)经历了至少1次突然入睡的发作;在3(0.7%)中,发生此事件时没有发出警告。与车轮入睡相关的2个危险因素是Epworth嗜睡量表评分(比值比[OR]为1.14; 95%置信区间[CI]为1.06-1.24)和不适当的睡眠综合评分(OR为2.54; 95) %CI,1.76-3.66)。标准的Epworth嗜睡量表评分为7或更高,预测车轮后睡眠事件的75%的特异性为50%(排除与驾驶相关的问题可提供70%的敏感性和52%的特异性),而1分则为不适当的睡眠综合评分产生了52%的敏感性和82%的特异性。结论:即使在独立且没有痴呆的PD患者中,白天过度嗜睡也是常见的。突然发作而没有警告的睡眠很少。 Epworth评分具有足够的敏感性,可以预测驾车前入睡的发作情况,其特异性可以通过使用不合适的睡眠综合评分来提高。目前尚不清楚例行进行这些评估是否可以更有效地预测这些罕见睡眠发作的未来风险。如果在特殊情况下打do睡,应警告患者不要开车。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号